Gilead Sciences Inc (NAS:GILD)
$ 67.6 -0.26 (-0.38%) Market Cap: 84.22 Bil Enterprise Value: 104.94 Bil PE Ratio: 187.78 PB Ratio: 4.80 GF Score: 77/100

Gilead Sciences Inc at Evercore ISI HealthCONx Conference Transcript

Dec 02, 2020 / 04:20PM GMT
Release Date Price: $61.13 (+0.02%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Excellent. Listen guys, thank you so much for joining us. It's a huge pleasure to have a broad representation from the Gilead management join us, from the R&D side, the commercial side, the Investor Relations side. Thank you guys so much for joining us.

Johanna Mercier
Gilead Sciences, Inc. - Chief Commercial Officer

Thrilled to be here. Thanks, Um.

Questions & Answers

Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Fantastic.

Merdad V. Parsey
Gilead Sciences, Inc. - Chief Medical Officer

Thank you.

Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

So just as we get started, I thought given the way this year evolved, maybe we should start off on COVID,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot